{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:13:50Z","timestamp":1791184430698,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.carpath.2011.07.005","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T21:03:50Z","timestamp":1314306230000},"page":"206-213","source":"Crossref","is-referenced-by-count":27,"title":["Elevated cyclic stretch and serotonin result in altered aortic valve remodeling via a mechanosensitive 5-HT2A receptor-dependent pathway"],"prefix":"10.1016","volume":"21","author":[{"given":"Kartik","family":"Balachandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiya","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon-Hwai","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralidhar","family":"Padala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian H.","family":"Chester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit P.","family":"Yoganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.carpath.2011.07.005_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCULATIONAHA.105.593459","article-title":"Serotonin transporter mechanisms and cardiac disease","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.carpath.2011.07.005_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00702-008-0179-4","article-title":"Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review","volume":"116","author":"Steiger","year":"2009","journal-title":"J Neural Transm"},{"issue":"3","key":"10.1016\/j.carpath.2011.07.005_bb0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/07853890008998827","article-title":"Serotonin and the heart","volume":"32","author":"Frishman","year":"2000","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.carpath.2011.07.005_bb0020","first-page":"822","article-title":"Influence of 5-hydroxytryptamine on aortic valve competence in vitro","volume":"10","author":"Chester","year":"2001","journal-title":"J Heart Valve Dis"},{"issue":"3","key":"10.1016\/j.carpath.2011.07.005_bb0025","first-page":"454","article-title":"Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents","volume":"9","author":"Hafizi","year":"2000","journal-title":"J Heart Valve Dis"},{"issue":"9","key":"10.1016\/j.carpath.2011.07.005_bb0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine\u2013phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.carpath.2011.07.005_bb0035","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0002-9440(10)64489-6","article-title":"Serotonin mechanisms in heart valve disease: I. Serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells","volume":"161","author":"Jian","year":"2002","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.carpath.2011.07.005_bb0040","first-page":"250","article-title":"Receptor-mediated contraction of aortic valve leaflets","volume":"9","author":"Chester","year":"2000","journal-title":"J Heart Valve Dis"},{"issue":"16","key":"10.1016\/j.carpath.2011.07.005_bb0045","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jacc.2008.11.056","article-title":"Endothelium-dependent regulation of the mechanical properties of aortic valve cusps","volume":"53","author":"El-Hamamsy","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4-5","key":"10.1016\/j.carpath.2011.07.005_bb0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.etp.2008.03.005","article-title":"5-Hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats","volume":"60","author":"Elangbam","year":"2008","journal-title":"Exp Toxicol Pathol"},{"issue":"1","key":"10.1016\/j.carpath.2011.07.005_bb0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.carpath.2011.07.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2011.03.008","article-title":"Serotonin receptors and heart valve disease\u2014It was meant 2B","author":"Hutcheson","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.carpath.2011.07.005_bb0065","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/S0002-9440(10)64497-5","article-title":"Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells","volume":"161","author":"Xu","year":"2002","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.carpath.2011.07.005_bb0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cardiores.2006.08.003","article-title":"Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes","volume":"72","author":"Liang","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.carpath.2011.07.005_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjp.0703011","article-title":"Evidence that activation of central 5-HT(2B) receptors causes renal sympathoexcitation in anaesthetized rats","volume":"129","author":"Knowles","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.carpath.2011.07.005_bb0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.yjmcc.2007.08.019","article-title":"Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle","volume":"43","author":"Brattelid","year":"2007","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.carpath.2011.07.005_bb0085","first-page":"256","article-title":"Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valve","volume":"9","author":"Roy","year":"2000","journal-title":"J Heart Valve Dis"},{"issue":"1","key":"10.1016\/j.carpath.2011.07.005_bb0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.athoracsur.2011.03.084","article-title":"Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor","volume":"92","author":"Balachandran","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"10.1016\/j.carpath.2011.07.005_bb0095","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s10439-006-9167-8","article-title":"An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch","volume":"34","author":"Balachandran","year":"2006","journal-title":"Ann Biomed Eng"},{"issue":"3","key":"10.1016\/j.carpath.2011.07.005_bb0100","doi-asserted-by":"crossref","first-page":"H756","DOI":"10.1152\/ajpheart.00900.2008","article-title":"Elevated cyclic stretch alters matrix remodeling in aortic valve cusps - implications for degenerative aortic valve disease?","volume":"296","author":"Balachandran","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.carpath.2011.07.005_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2353\/ajpath.2010.090631","article-title":"Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner","volume":"177","author":"Balachandran","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.carpath.2011.07.005_bb0110","series-title":"The aortic valve","first-page":"221","author":"Thubrikar","year":"1990"},{"issue":"2","key":"10.1016\/j.carpath.2011.07.005_bb0115","doi-asserted-by":"crossref","first-page":"H395","DOI":"10.1152\/ajpheart.00040.2009","article-title":"Dynamic deformation characteristics of porcine aortic valve leaflet under normal and hypertensive conditions","volume":"298","author":"Yap","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.carpath.2011.07.005_bb0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1667\/RR2036.1","article-title":"Serum serotonin levels determine the magnitude and type of bystander effects in medium transfer experiments","volume":"174","author":"Mothersill","year":"2010","journal-title":"Radiat Res"},{"issue":"24","key":"10.1016\/j.carpath.2011.07.005_bb0125","first-page":"1773","article-title":"Valvular heart disease associated with fenfluramine\u2013phentermine","volume":"337","author":"Redmon","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.carpath.2011.07.005_bb0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjcard.2006.07.092","article-title":"Carcinoid heart disease in patients without hepatic metastases","volume":"99","author":"Bernheim","year":"2007","journal-title":"Am J Cardiol"},{"issue":"12 Suppl 1","key":"10.1016\/j.carpath.2011.07.005_bb0135","doi-asserted-by":"crossref","first-page":"I36","DOI":"10.1161\/hc37t1.094898","article-title":"Surgical management of left-sided carcinoid heart disease","volume":"104","author":"Connolly","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.carpath.2011.07.005_bb0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijcard.2008.02.019","article-title":"Carcinoid heart disease","volume":"129","author":"Gustafsson","year":"2008","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.carpath.2011.07.005_bb0145","first-page":"827","article-title":"Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects","volume":"10","author":"Rajamannan","year":"2001","journal-title":"J Heart Valve Dis"},{"issue":"6","key":"10.1016\/j.carpath.2011.07.005_bb0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/j.1552-4604.1995.tb05013.x","article-title":"Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease","volume":"35","author":"Frishman","year":"1995","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.carpath.2011.07.005_bb0155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/0192623310378027","article-title":"Drug-induced valvulopathy: an update","volume":"38","author":"Elangbam","year":"2010","journal-title":"Toxicol Pathol"},{"issue":"6","key":"10.1016\/j.carpath.2011.07.005_bb0160","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3,4-Methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.carpath.2011.07.005_bb0165","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00210-004-0951-4","article-title":"Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors","volume":"370","author":"Knight","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"12","key":"10.1016\/j.carpath.2011.07.005_bb0170","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jbiomech.2009.05.015","article-title":"On the biomechanics of heart valve function","volume":"42","author":"Sacks","year":"2009","journal-title":"J Biomech"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880711000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880711000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T05:21:22Z","timestamp":1741497682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880711000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1054880711000834"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2011.07.005","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}